Replacement of Glutamic Acid with Arginine : This modification prevents binding to IGF-binding proteins, enhancing bioavailability
It is not yet approved by the FDA or Health Canada, but early clinical trial data has generated significant excitement
Acta Neuropathol Commun 5:48
With the development of ADC approach, PBD has been used as a payload associated with specific antibodies in the treatment of different diseases, limiting the high toxicity associated with this molecule
Description CJC-1295 & Ipamorelin Peptide Blend Chemical Makeup CJC-1295 (with DAC): Molecular Formula: C165H269N47O46 Molecular Weight: ~3647.10 g/mol Half-Life: ~58 days with DAC Ipamorelin: Molecular Formula: C49H74N14O10 Molecular Weight: ~711.9 g/mol Half-Life: ~2 hours Form: Lyophilized powder blend Solubility: Water-soluble (reconstitution with bacteriostatic water) Research Use Only The CJC-1295 & Ipamorelin blend is intended solely for in vitro and in vivo laboratory research
The temperature of the stage was controlled using a temperature controller (Linkam Scientific Instruments, T96) and a water circulation bath (VWR) circulating water within the cooling stage to allow cooling to 40 C
